Healthcare Triangle raises $1.63 million through warrant exercise

PLEASANTON, CA - Healthcare Triangle, Inc. (Nasdaq:HCTI), a digital transformation solutions provider for healthcare and life sciences with a market capitalization of $17.03 million, announced Thursday it has entered into warrant exercise agreements with three existing accredited investors, generating approximately $1.63 million in gross proceeds. The company has shown strong momentum with a 14.51% return over the past week, according to InvestingPro data.

The transaction involves the immediate exercise of warrants to purchase 812,775 shares of the company’s common stock. As part of the agreement, HCTI reduced the exercise price of these existing warrants from $20.92 to $2.00 per share.

In exchange for exercising these warrants, the investors will receive new unregistered warrants to purchase an additional 812,775 shares at an exercise price of $3.00 per share. These new warrants will become exercisable once stockholder approval is obtained and will expire five years from the approval date.

The transaction is expected to close on October 2, 2025, subject to customary closing conditions. WallachBeth Capital is serving as the sole placement agent for the warrant inducement transaction.

Healthcare Triangle, which recently achieved HITRUST Certification for its Cloud and Data Platform, provides services to hospitals, health systems, payers, and pharmaceutical companies. The company specializes in digital transformation encompassing cloud services, security and compliance, data management, and healthcare interoperability.

The information in this article is based on a company press release statement.

In other recent news, Healthcare Triangle, Inc. has announced several significant developments. The company reported that its subsidiary, QuantumNexis, has secured strategic partnerships in Malaysia, potentially generating approximately $2 million in revenue. This expansion into Southeast Asia occurred within 45 days of QuantumNexis’ launch. Furthermore, Healthcare Triangle plans to implement a 1-for-249 reverse stock split, effective August 1, 2025, which will result in a new CUSIP number for its shares on the Nasdaq Capital Market. In a related matter, Healthcare Triangle has secured continued listing on the Nasdaq Stock Market after a review by the Nasdaq Hearings Panel. The panel’s decision requires the company to complete the reverse stock split by August 8, 2025, and maintain a $1 closing bid price for at least twenty consecutive trading days by September 5, 2025. These recent developments highlight Healthcare Triangle’s strategic moves to expand its market presence and address compliance requirements.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.